tirofiban has been researched along with Coronary Occlusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Wang, B; Wang, W; Wei, S | 1 |
| Huang, H; Ouyang, F; Peng, H; Yin, Y; Zeng, J; Zhou, X | 1 |
| Valgimigli, M | 1 |
3 other study(ies) available for tirofiban and Coronary Occlusion
| Article | Year |
|---|---|
Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis.
Topics: Acute Disease; Adult; Aftercare; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Cytochrome P-450 CYP2C19; Dual Anti-Platelet Therapy; Female; Fibrinolytic Agents; Humans; Integrin alpha2; Mutation; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Stents; Thrombectomy; Thrombosis; Ticagrelor; Tirofiban; Treatment Outcome | 2021 |
Diffused alveolar hemorrhage: A rare and severe complication of tirofiban-induced thrombocytopenia.
Topics: Aged; Coronary Occlusion; Hemorrhage; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Thrombocytopenia; Tirofiban; Tyrosine | 2016 |
AMI on the move.
Topics: Accelerated Idioventricular Rhythm; Ambulances; Angioplasty, Balloon, Coronary; Coronary Occlusion; Delivery of Health Care, Integrated; Electrocardiography; Emergency Medical Services; Female; Fibrinolytic Agents; Gene Expression Profiling; Health Services Accessibility; Hemodynamics; Humans; Male; Myocardial Infarction; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; RNA, Messenger; Telemetry; Tirofiban; Transcription, Genetic; Tyrosine | 2011 |